Day: May 16, 2022

Posted on

FCET thanks Punjab University Vice Chancellor 

Lahore, May 16, 2022 (PPI-OT):Punjab University Vice Chancellor Prof Niaz Ahmad visited Faculty of Chemical Engineering and Technology. PU Dean Faculty of Engineering and Technology Prof Abdullah Khan Durrani, heads of various departments, teachers, employees and students thanked PU VC for resolving their long-standing issues regarding appointments, promotions and quality education, which contributed to improvement of international ranking of the faculty as well as university. They said that due to PU VC’s efforts, PU has been ranked among world’s top 101-150 universities in the subject of Petroleum Engineering, which is an unbelievable achievement.

For more information, contact:
Registrar,
University of the Punjab
Quaid-e-Azam Campus, Lahore, Pakistan
Tel: +92-42-99231102
Fax: +92-42-99231103
E-Mail: registrar@pu.edu.pk
Website: http://pu.edu.pk/

Posted on

Students of Electronics and Electrical Systems conduct a study tour to Tarbela Power House

Lahore, May 16, 2022 (PPI-OT):More than 40 students from semester 5th to 8th of BS-Electronics and Electrical System under the supervision Mr. Muhammad Wajahat Hassan (Assistant Professor, EES) and Engr. Muhammad Aamer (Assistant Professor, EES) visited Tarbela Power House on March 26, 2022. The tour that was aimed at exposing the students to the practical elements of electrical systems was arranged by UOL’s Electronics Club in association with the Department of Electronics and Electrical Systems (EES).

The Tarbela Power Station, located on the Indus River about 50 km northwest of the capital Islamabad, was first finalized in 1976. Its dam is one of the largest earth-filled dams in the world and also the second largest by structural volume, creating an impressive reservoir with a surface area of approximately 250 m2.

For more information, contact:
The University of Lahore
1 – KM Defence Road, Lahore, Pakistan
Tel: +92-42-111-865-865, +92-42-35322501 +92-42-35321761
Email: info@uol.edu.pk
Website: www.uol.edu.pk

Posted on

Department of Computer Engineering holds multiple skill-based trainings 

Lahore, May 16, 2022 (PPI-OT):The Department of Computer Engineering conducted multiple 0.5 Continuing Professional Development (CPD) credit point skill-based multiple trainings for the students at the University of Lahore (UOL) main Defence Road Campus in the month of March.

On March 7, 2022, a CPD training (0.5 points) on “Integration and Exploitation of Renewable and Wind Energy Sources in Smart Power System”. The training under the facilitation of Engr. Ihsan Ullah (Assistant Professor, Computer Engineering) targeted UOL’s Pakistan Engineering Council (PEC) registered students and professionals to enhance their knowledge and skills. This training was arranged to familiarize the participants with the current status of large, grid-connected photovoltaic (PV) and wind energy, its benefits, constraints to development, as well as strategies for mitigating negative impacts and overcoming barriers to investment.

During the training session, the participants were addressed on increasing complexity of the existing power grid due to rapid population growth, development in technology, infrastructure and computational tools. The speaker also discussed the factors that contribute to the need for the deployment of a smart grid for secure and efficient use of energy. The session discussed the availability of solar, wind energy and its usage, wind technology issues, the global status of PV and wind power generation and investment costs.

On March 10, 2022, Engr. Dr. Muhammad Wasim Nawaz (Assistant Professor, Computer Engineering addressed the use of machine learning (ML), image classification and neural networks in software development. This skill enhancement session on “Deep Neural Networks for Image Classification” aimed at updating the students on how deep learning algorithms can function in mimicking the human brain and how a computer system can identify and recognize different images.

“Inspired by the human vision system, Artificial Neural Networks (ANNs) are created by researchers, which is a subfield of machine learning. ANNs are inspired by information processing and distributed communication nodes in biological nervous systems,” he explained.

In another skill-based training session about “Recent research trends in Wireless Communication” on March 15, 2022, Engr. Dr. Naveed Ur Rehman (Assistant Professor, Computer Engineering) informed PEC registered engineers, faculty and students about the evolution of mobile generation from 1G to 5G and beyond.

Furthermore, some research areas for 4G, 5G and 6G were discussed in detail such as OFDM, Massive MIMO, SM-MIMO, NOMA, compressive sensing applications in detection and signal processing, Artificial Intelligence in Wireless Communication, Resource Allocation and frequency reuse.

For more information, contact:
The University of Lahore
1 – KM Defence Road, Lahore, Pakistan
Tel: +92-42-111-865-865, +92-42-35322501 +92-42-35321761
Email: info@uol.edu.pk
Website: www.uol.edu.pk

Posted on

UMT Faculty Sweeps Funding for 4 More Research Projects from HEC-NRPU

Lahore, May 16, 2022 (PPI-OT):The Office of Research Innovation and Commercialization (ORIC) at the University of Management and Technology (UMT) is proud of the extraordinary achievement of our faculty. They have won funding for four more research projects from the National Research Program for Universities (NRPU) by the Higher Education Commission of Pakistan.

The credit for this outstanding success goes to the honoured faculty members of the School of Food and Agricultural Sciences (SFAS), Department of Mathematics and Department of Chemistry of the School of Science (SSC) and School of Systems and Technology (SST), Sialkot Campus.

The details of the NRPU projects winners are:

Dr Naveen Kosar (won 320,7350/- PKR)

Dr Rubab Manzoor (won 208,1500/- PKR)

Dr Hafiz Ubaid Ur Rahman and Dr Nauman Khalid (won 681,9500/- PKR)

Dr Muhammad Wasim (won 5652250/- PKR)

The ORIC team will facilitate these projects until their completion. As always, ORIC remains committed to its endeavours to support the faculty in conducting applied research at UMT. This achievement will also encourage other UMT faculty members to apply for research grants with the same zeal.

For more information, contact:
Media Coordinator,
University of Management and Technology (UMT)
C-II, Johar Town, Lahore, Pakistan
UAN: +92-42-111-300-200
Tel: +92-42-35212801-10
Fax: +92-42-35184789
Email: yaqoob@umt.edu.pk
Website: https://www.umt.edu.pk

Posted on

Inflation (17%) and governance (17%) are believed to be two of the biggest problems that Islamabad faces: A representative survey of Islamabad by Gallup Pakistan

Islamabad, May 16, 2022 (PPI-OT):According to a survey conducted by Gallup and Gilani Pakistan, inflation (17%) and governance (17%) are believed to be two of the biggest problems that Islamabad faces.

A nationally representative sample of adult men and women from across the capital was asked the following question, “What is the biggest problem that Islamabad faces?”. In response to this question, 17% said governance, 17% said inflation, 13% said water issue, 12% said utilities, 10% said transport, 4% said environmental issues, 2% said social issues, 5% said others and 20% said there wasn’t any issue in Islamabad.

Question: “What is the biggest problem that Islamabad faces?”

For more information, contact:
Head Office,
Gallup Pakistan
Islamabad, Pakistan
Tel: +92-51-8445080
Email: isb@gallup.com.pk, caf@gallup.com.pk
Website: www.gallup.com.pk

Posted on

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the submission of an investigational new drug (IND) application to the China National Medical Products Administration (NMPA) for the initiation of a Phase 1/2 clinical study of ZB001 for the treatment of Thyroid Eye Disease (TED). This study is designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZB001.

“The ZB001 IND submission to the NMPA marks a significant milestone for Zenas,” said Hua Mu, MD, PhD, Chief Executive Officer at Zenas. “There are currently no approved therapies for TED patients in China. Treatment options are limited and often involve high doses of steroids associated with serious side effects or surgical intervention. ZB001 has the potential to change the treatment paradigm for TED patients in China.”

ZB001 is a differentiated humanized monoclonal antibody targeting insulin-like growth factor 1 receptor (IGF-1R) for the treatment of TED. TED is a debilitating autoimmune disease that causes inflammation and fibrosis within the orbit of the eye, which can cause double vision, pain, and potential blindness. Patients with severe disease often require multiple remedial surgeries to the orbit, eye muscles and eyelids.

Zenas BioPharma licensed the exclusive rights to develop, manufacture and commercialize ZB001 (Viridian VRDN-001) and other compounds targeting IGF-1R in non-oncology indications in the greater area of China from Viridian Therapeutics, Inc. (Viridian) in October 2020. In October 2021, Viridian submitted an IND for VRDN-001 to the U.S. Food and Drug Administration and in December 2021 initiated a Phase 1/2 clinical trial to evaluate proof of concept in TED patients in North America.

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and commercialization of immune-based therapies for patients in the US, China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn.

Investor and Media Contact:
Joe Farmer
Zenas BioPharma
IR@zenasbio.com